Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Katherine Rylant

Physician Assistant Lawrenceville, GA Physician Assistant

NPI 1780103432 CMS profile 10659701

758 Old Norcross Rd Ste 100, Lawrenceville, GA 30046

Open in the dashboard

General payments

$3,009

130 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Katherine Rylant of Lawrenceville, GA is reported in the CMS Open Payments database as having received $3,009 across 130 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 86th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $56 2
2024 General $155 3
2023 General $41 3
2022 General $1,302 63
2021 General $1,455 59

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Katherine Rylant
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Katherine Rylant were reported at $56. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Katherine Rylant Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $1,455 $132 $37–$438 $132
2022 $1,302 $155 $48–$522 $149
2023 $41 $167 $52–$557 $160
2024 $155 $178 $55–$600 $164
2025 $56 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Novo Nordisk Inc $863 36 payments
  2. AbbVie, Inc. $396 14 payments
  3. Lilly USA, LLC $210 13 payments
  4. Amgen Inc. $198 13 payments
  5. Novartis Pharmaceuticals Corporation $157 5 payments
  6. AstraZeneca Pharmaceuticals LP $150 3 payments
  7. Pacira Pharmaceuticals Incorporated $122 1 payment
  8. Takeda Pharmaceuticals U.S.A., Inc. $118 6 payments
  9. Inspire Medical Systems, Inc. $117 1 payment
  10. Amarin Pharma Inc. $116 7 payments
  11. Other $563 31 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $3,009 130 payments
Products named General payments · program years 2021–2025
  1. RYBELSUS $703 24 payments
  2. Ozempic $340 21 payments
  3. LEQVIO $157 5 payments
  4. FARXIGA $150 3 payments
  5. UBRELVY $146 3 payments
  6. VRAYLAR $123 2 payments
  7. Iovera $122 1 payment
  8. TRINTELLIX $118 6 payments
  9. Inspire Upper Airway Stimulation System $117 1 payment
  10. Vascepa $116 7 payments
  11. Other $1,730 108 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 13 drugs

Part D claims

741

Median for Physician Assistant: 241

Drug cost

$4,815

Median for Physician Assistant: $4,110

Branded share of claims

0%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 101 $1,598
Diclofenac Sodium Generic 86 $1,093
Meloxicam Generic 225 $533
Methylprednisolone Generic 82 $405
Ibuprofen Generic 39 $360
Ketorolac Tromethamine Generic 18 $198
Gabapentin Generic 16 $159
Tramadol Hcl Generic 78 $155
Cyclobenzaprine Hcl Generic 30 $137
Cephalexin Generic 14 $68

The 10 drugs with the highest cost, of 13 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 46 billing codes

Paid by Medicare

$166,779

Of which drugs: $103,850

Medicare patients

324

Average age 75

Services billed

21,296

208 women, 116 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 29%
Ischemic heart disease 27%
Chronic kidney disease 20%
Depression 19%
Osteoporosis 19%
Cancer 17%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, triluron, for intra-articular injection, 1 mg J7332 Office 130 11,720 $93,717
Injection, methylprednisolone acetate, 1 mg J1010 Office 100 7,761 $770
Injection, methylprednisolone acetate, 40 mg J1030 Office 36 38 $131
Injection, methylprednisolone acetate, 80 mg J1040 Office 13 14 $84

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
SYNTHROID
  • AbbVie, Inc. $33
$33 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

130 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record